Name: Lexeo Therapeutics, Inc. (LXEO) Balance Sheet
Creator: FinSpry

Lexeo Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Lexeo Therapeutics, Inc. (LXEO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	35.01	121.47	77.34	135.86	29.37
Short-Term Investments	86.50	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	121.52	121.47	77.34	135.86	29.37
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	4.60	0.00	0.37	0.13	0.00
Total Current Assets	126.12	124.29	80.05	136.68	29.41
Non-Current Assets
Property, Plant & Equipment (Net)	10.56	12.26	13.78	0.17	0.00
Long-Term Investments	7.01	0.00	0.00	0.00	0.00
Other Non-Current Assets	3.25	3.25	3.25	0.00	0.00
Total Non-Current Assets	20.82	15.51	17.03	0.18	0.00
Total Assets	146.94	139.81	97.08	136.86	29.41
Current Liabilities
Accounts Payable	6.42	3.79	2.68	3.06	0.04
Short-Term Debt	2.67	0.00	0.00	0.00	0.00
Accrued Liabilities	9.10	10.29	6.18	3.78	0.25
Deferred Revenue	0.00	0.00	0.00	0.05	0.14
Other Current Liabilities	13.76	10.84	0.24	0.03	0.22
Total Current Liabilities	22.85	17.24	14.35	7.45	0.70
Non-Current Liabilities
Long-Term Debt	7.25	9.03	10.65	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	3.01
Total Non-Current Liabilities	7.25	9.03	195.68	185.01	0.00
Total Liabilities	30.10	26.27	210.03	7.45	3.71
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-280.17	-181.84	-115.45	-56.17	-5.55
Accumulated Other Comprehensive Income	-0.10	0.00	0.00	0.00	0.00
Treasury Stock	-0.02	0.00	0.00	0.00	0.00
Additional Paid-in Capital	397.13	295.37	2.49	0.57	0.00
Shares Outstanding	33.08	26.65	25.17	25.17	0.00
Total Stockholders' Equity	116.84	113.54	-112.95	129.41	25.70
Total Liabilities & Equity	146.94	139.81	97.08	136.86	0.00